Cameroon Launches Malaria Vaccination

Cameroon’s malaria vaccination program is a significant milestone in the fight against the disease in Africa.

The first of its kind globally, the program could significantly reduce severe infections and hospitalizations.

The vaccine, approved by the World Health Organisation two years ago, is only about 30% effective and requires four doses.

However, it has been studied for over nine years, with most reported side effects being fever, swelling at the injection site, and irritability.

Experts suggest that basic measures to stop transmission, such as mosquito nets and sprays, are still crucial.

Cameroon aims to vaccinate about 250,000 children this year and next year, with the hope of a rapid decline in malaria morbidity and mortality. The vaccine is expected to complete the range of tools for preventing malaria.

It’s official!

Cameroon🇨🇲 has now introduced the RTS,S malaria vaccine into its expanded vaccination programme, following a 4-dose schedule.
Baby Daniella is the first baby to be vaccinated!#VaccinesWork pic.twitter.com/GIYhS8lpBw

— WHO African Region (@WHOAFRO) January 22, 2024